Rafael Holdings RFL
NYSE RFL
$1.49 -0.01 (-0.66%)
As of: Oct 2, 2026 · 11:36 AM EDT

Rafael Holdings (RFL) Non Operating Interest Expenses (2021 - 2026)

Updated

Rafael Holdings (RFL) recorded Non Operating Interest Expenses of $6,000 in fiscal Q3 2026 (quarter ended Apr 30, 2026), down 96.4% from $165,000 a year earlier and down 96.3% from the prior quarter.

Analysis

Rafael Holdings (RFL) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

On a TTM basis, Rafael Holdings' Non Operating Interest Expenses came in at $495,000 as of Apr 30, 2026, down 24.2% year-over-year; for FY2025 (ended Jul 31, 2025), it came in at $658,000, up 165.3% from FY2024.

  • Annual Non Operating Interest Expenses has a four-year compound annual growth rate of 79.1% (FY2021 to FY2025).
  • Across earlier fiscal years, Non Operating Interest Expenses came in at $248,000 in FY2024 (+185.1%), $87,000 in FY2023, $6,000 in FY2022 (-90.6%) and $64,000 in FY2021.
  • The fiscal Q3 2026 figure is the lowest quarterly Non Operating Interest Expenses since fiscal Q4 2022.
  • On a year-over-year basis, Non Operating Interest Expenses has declined for three consecutive quarters, with growth averaging 14.3% over the last six quarters.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 94.1% in fiscal Q3 2025, against a decline of 96.4% in fiscal Q3 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $161,000 (Q2 2026), $160,000 (Q1 2026) and $168,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rafael Holdings 68.10 Mn 73.52 Mn 163,000.00 6,000.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 6,000.00
Jan 31, 2026 161,000.00
Oct 31, 2025 160,000.00
Jul 31, 2025 168,000.00
Apr 30, 2025 165,000.00
Jan 31, 2025 163,000.00
Oct 31, 2024 162,000.00
Jul 31, 2024 163,000.00
Apr 30, 2024 85,000.00
Jul 31, 2023 87,000.00
Oct 31, 2022 87,000.00
Jul 31, 2022 -13,000.00
Apr 30, 2022 1,000.00
Jan 31, 2022 87,000.00
Oct 31, 2021 271,000.00
Jul 31, 2021 59,000.00
Apr 30, 2021 3,000.00
API Access

Rafael Holdings Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RFL&period=max&api_key=YOUR_API_KEY